Metropolis Healthcare Limited
NSE: METROPOLIS.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Surendran Chemmenkotil
- Employees
- 4,313
- Headquarters
- Mumbai, India
- IPO year
- 2019
- Market cap
- ₹113.9B
- Website
- https://www.metropolisindia.com
Loading METROPOLIS…
Loading profile data…Frequently asked questions about METROPOLIS
What does Metropolis Healthcare Limited (METROPOLIS.NS) do?
Metropolis Healthcare Limited provides diagnostic services in India. It offers clinical laboratory testing, and profiles and support services. The company provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tes...
Where does METROPOLIS.NS trade?
Metropolis Healthcare Limited (METROPOLIS.NS) trades on the National Stock Exchange of India.
What sector is METROPOLIS.NS in?
Metropolis Healthcare Limited (METROPOLIS.NS) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Metropolis Healthcare Limited?
Surendran Chemmenkotil is the chief executive officer of Metropolis Healthcare Limited (METROPOLIS.NS).
Where is Metropolis Healthcare Limited headquartered?
Metropolis Healthcare Limited is headquartered in India.
Does METROPOLIS.NS pay a dividend?
Yes — Metropolis Healthcare Limited (METROPOLIS.NS) paid a trailing twelve-month dividend of INR 1.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did METROPOLIS.NS go public?
Metropolis Healthcare Limited (METROPOLIS.NS) completed its initial public offering in 2019.